HomeEXECUTIVESPerimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech...

Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing

Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – today announced the appointment of experienced medtech sales executive, Adam Hodges, as its Vice President, Sales and Marketing, effective immediately.

Adrian Mendes, Perimeter’s Chief Executive Officer stated, “I am excited to welcome Adam to the Perimeter team as our senior leader responsible for the strategy and execution of our sales-related goals. Adam’s extensive medtech background represents a great fit, with his focus on advancing category-first, novel technologies that challenge the clinical standard of care and add value to the healthcare system. We believe our market development managers and other team members in the field will benefit from his leadership as we expand the number of surgeon champions and geographical regions adopting our commercially available S-Series OCT medical imaging platform. Looking ahead, I expect Adam will also play a key role driving the expansion and adoption of our next-gen AI-enabled B-Series technology – which is currently in development – when it reaches a commercial roll-out stage.”

Adam Hodges brings more than 20 years of commercialization experience in the medical device industry. Most recently, Adam was Vice President of Sales at SIA Health, leading the commercial acceleration of DuraSorb®, which was acquired by Integra LifeSciences (NASDAQ: IART) in December 2022. During his tenure at SIA, Adam grew sales revenue by more than 5X in less than two years and previously served concurrent roles of Vice President of Strategic Accounts and Regional Business Director.

Prior to that, Adam Hodges was VP of Strategic Accounts for Vapotherm (NYSE: VAPO), driving core commercial acceleration and identifying and growing adjacent markets for a novel respiratory therapy technology. From 2009 to 2019, Adam worked at Medtronic in various roles, including Director of Strategic Accounts, Senior Regional Business Director, and Account Manager.

Earlier in his career, Adam Hodges was an Executive Surgical Device Specialist for United States Surgical (Covidien/Medtronic) and a Sales Representative for Johnson & Johnson. Adam began his career in 1998 as a Change Management Consultant for Accenture. Adam received a Bachelor’s degree in English from Samford University and then went on to receive a Master of Business Administration (M.B.A.) in Organizational Leadership from Lipscomb University.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


Dr Charles R Gordon was the founding Chairman of the Board for Baylor Scott & White's Texas Spine & Joint Hospital. Over the years the hospital has grown, and majority interest of the hospital was sold to Baylor Scott & White and United Surgical Partners International (USPI).
"We are excited to welcome Jeff Anderson to Nutjobs as our new CEO. His broad experience and tactical leadership will be instrumental in executing against our vision to provide innovative, sustainable solutions to our customers," said Paul Kephart, Co-Founder, Chief Technology Officer and Chairperson of the Nutjobs Board.
Potrero Medical believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care.
Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.

By using this website you agree to accept Medical Device News Magazine Privacy Policy